292 related articles for article (PubMed ID: 31209498)
1. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
Hilvo M; Meikle PJ; Pedersen ER; Tell GS; Dhar I; Brenner H; Schöttker B; Lääperi M; Kauhanen D; Koistinen KM; Jylhä A; Huynh K; Mellett NA; Tonkin AM; Sullivan DR; Simes J; Nestel P; Koenig W; Rothenbacher D; Nygård O; Laaksonen R
Eur Heart J; 2020 Jan; 41(3):371-380. PubMed ID: 31209498
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
[TBL] [Abstract][Full Text] [Related]
3. Plasma Ceramides.
Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
[TBL] [Abstract][Full Text] [Related]
4. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
[TBL] [Abstract][Full Text] [Related]
5. Association between ceramides and coronary artery stenosis in patients with coronary artery disease.
Tu C; Xie L; Wang Z; Zhang L; Wu H; Ni W; Li C; Li L; Zeng Y
Lipids Health Dis; 2020 Jun; 19(1):151. PubMed ID: 32586390
[TBL] [Abstract][Full Text] [Related]
6. CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis.
Papazoglou AS; Stalikas N; Moysidis DV; Otountzidis N; Kartas A; Karagiannidis E; Giannakoulas G; Sianos G
J Clin Lipidol; 2022; 16(3):272-276. PubMed ID: 35219648
[TBL] [Abstract][Full Text] [Related]
7. Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.
Mantovani A; Bonapace S; Lunardi G; Salgarello M; Dugo C; Gori S; Barbieri E; Verlato G; Laaksonen R; Byrne CD; Targher G
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2854-2861. PubMed ID: 30571175
[TBL] [Abstract][Full Text] [Related]
8. Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.
Jansen H; Jaensch A; Schöttker B; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
J Am Heart Assoc; 2019 Jun; 8(12):e011882. PubMed ID: 31189389
[TBL] [Abstract][Full Text] [Related]
9. Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients.
Leiherer A; Mündlein A; Laaksonen R; Lääperi M; Jylhä A; Fraunberger P; Drexel H
Eur J Prev Cardiol; 2022 May; 29(6):947-956. PubMed ID: 34417607
[TBL] [Abstract][Full Text] [Related]
10. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.
Laaksonen R; Ekroos K; Sysi-Aho M; Hilvo M; Vihervaara T; Kauhanen D; Suoniemi M; Hurme R; März W; Scharnagl H; Stojakovic T; Vlachopoulou E; Lokki ML; Nieminen MS; Klingenberg R; Matter CM; Hornemann T; Jüni P; Rodondi N; Räber L; Windecker S; Gencer B; Pedersen ER; Tell GS; Nygård O; Mach F; Sinisalo J; Lüscher TF
Eur Heart J; 2016 Jul; 37(25):1967-76. PubMed ID: 27125947
[TBL] [Abstract][Full Text] [Related]
11. Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly.
Katajamäki TT; Koivula MK; Hilvo M; Lääperi MTA; Salminen MJ; Viljanen AM; Heikkilä ETM; Löppönen MK; Isoaho RE; Kivelä SL; Jylhä A; Viikari L; Irjala KM; Pulkki KJ; Laaksonen RMH
Clin Chem; 2022 Dec; 68(12):1502-1508. PubMed ID: 36308332
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
13. Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus.
Hilvo M; Jylhä A; Lääperi M; Jousilahti P; Laaksonen R
Eur Heart J Open; 2021 Nov; 1(3):oeab010. PubMed ID: 35919880
[TBL] [Abstract][Full Text] [Related]
14. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.
Peterson LR; Xanthakis V; Duncan MS; Gross S; Friedrich N; Völzke H; Felix SB; Jiang H; Sidhu R; Nauck M; Jiang X; Ory DS; Dörr M; Vasan RS; Schaffer JE
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728014
[TBL] [Abstract][Full Text] [Related]
15. Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.
Hilvo M; Vasile VC; Donato LJ; Hurme R; Laaksonen R
Front Endocrinol (Lausanne); 2020; 11():570628. PubMed ID: 33133018
[TBL] [Abstract][Full Text] [Related]
16. Ceramide Scores Predict Cardiovascular Risk in the Community.
Vasile VC; Meeusen JW; Medina Inojosa JR; Donato LJ; Scott CG; Hyun MS; Vinciguerra M; Rodeheffer RR; Lopez-Jimenez F; Jaffe AS
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1558-1569. PubMed ID: 33596665
[TBL] [Abstract][Full Text] [Related]
17. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
[TBL] [Abstract][Full Text] [Related]
18. Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.
Wretlind A; Curovic VR; Suvitaival T; Theilade S; Tofte N; Winther SA; Vilsbøll T; Vestergaard H; Rossing P; Legido-Quigley C
Diabetes; 2023 Oct; 72(10):1493-1501. PubMed ID: 37478203
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study.
Cheng JM; Suoniemi M; Kardys I; Vihervaara T; de Boer SP; Akkerhuis KM; Sysi-Aho M; Ekroos K; Garcia-Garcia HM; Oemrawsingh RM; Regar E; Koenig W; Serruys PW; van Geuns RJ; Boersma E; Laaksonen R
Atherosclerosis; 2015 Dec; 243(2):560-6. PubMed ID: 26523994
[TBL] [Abstract][Full Text] [Related]
20. Associations between plasma ceramides and mortality in patients with coronary artery disease.
Li Q; Wang X; Pang J; Zhang Y; Zhang H; Xu Z; Chen Q; Ling W
Atherosclerosis; 2020 Dec; 314():77-83. PubMed ID: 32980131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
